Joan Largent

2.1k total citations
58 papers, 1.5k citations indexed

About

Joan Largent is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Joan Largent has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Joan Largent's work include Cancer Risks and Factors (14 papers), Breast Cancer Treatment Studies (9 papers) and Botulinum Toxin and Related Neurological Disorders (7 papers). Joan Largent is often cited by papers focused on Cancer Risks and Factors (14 papers), Breast Cancer Treatment Studies (9 papers) and Botulinum Toxin and Related Neurological Disorders (7 papers). Joan Largent collaborates with scholars based in United States, United Kingdom and Germany. Joan Largent's co-authors include Hoda Anton‐Culver, Argyrios Ziogas, Leslie Bernstein, Michael G. Oefelein, Hilton M. Kaplan, Giske Ursin, Peggy Reynolds, Mitchell H. Brown, James D. Namnoum and Sarah F. Marshall and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joan Largent

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joan Largent United States	24	491	356	316	252	187	58	1.5k
Kim N. Danforth United States	24	345 0.7×	511 1.4×	182 0.6×	161 0.6×	179 1.0×	43	2.2k
Ahmet Alacacıoğlu Türkiye	25	948 1.9×	254 0.7×	236 0.7×	134 0.5×	71 0.4×	159	2.0k
Adetunji T. Toriola United States	24	794 1.6×	94 0.3×	239 0.8×	295 1.2×	151 0.8×	105	1.8k
Lewis H. Kuller United States	18	323 0.7×	180 0.5×	101 0.3×	361 1.4×	225 1.2×	25	2.0k
Anne Gulbech Ording Denmark	21	350 0.7×	178 0.5×	82 0.3×	112 0.4×	110 0.6×	90	1.6k
Heidi L. Miracle-McMahill United States	13	528 1.1×	82 0.2×	147 0.5×	207 0.8×	445 2.4×	17	1.3k
Merethe Kumle Norway	17	605 1.2×	54 0.2×	120 0.4×	348 1.4×	172 0.9×	24	1.1k
Jung Sub Lim South Korea	25	279 0.6×	231 0.6×	105 0.3×	323 1.3×	131 0.7×	94	2.2k
C. Langridge United Kingdom	18	535 1.1×	243 0.7×	406 1.3×	437 1.7×	127 0.7×	29	1.5k
Larry F. Ellison Canada	21	624 1.3×	201 0.6×	126 0.4×	299 1.2×	85 0.5×	47	1.7k

Countries citing papers authored by Joan Largent

Since Specialization

Citations

This map shows the geographic impact of Joan Largent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Largent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Largent more than expected).

Fields of papers citing papers by Joan Largent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Largent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Largent. The network helps show where Joan Largent may publish in the future.

Co-authorship network of co-authors of Joan Largent

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Largent. A scholar is included among the top collaborators of Joan Largent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Largent. Joan Largent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanz, Héctor, et al.. (2025). External Comparator Studies: Performance of Four Missing Data-Handling Approaches, Stratified by Four Different Marginal Estimators. Drug Safety. 48(12). 1413–1424.

Largent, Joan, et al.. (2024). Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies. SHILAP Revista de lepidopterología. 4. 1418050–1418050. 1 indexed citations

Largent, Joan, et al.. (2024). External Comparator Cohort studies - clarification of terminology. SHILAP Revista de lepidopterología. 3. 1321894–1321894. 4 indexed citations

Rough, Kathryn, et al.. (2024). Core Concepts in Pharmacoepidemiology: Principled Use of Artificial Intelligence and Machine Learning in Pharmacoepidemiology and Healthcare Research. Pharmacoepidemiology and Drug Safety. 33(11). e70041–e70041.

Sanz, Héctor, Wilhelmina E. Hoogendoorn, Nicolás Ballarini, et al.. (2024). Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations. Drug Safety. 47(12). 1245–1263. 2 indexed citations

Largent, Joan, Rachel E. Sobel, Marieke M.B. Seyger, et al.. (2023). A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting. European Journal of Dermatology. 33(1). 25–33. 2 indexed citations

Largent, Joan, et al.. (2023). Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry. BMJ Open. 13(6). e069118–e069118. 3 indexed citations

D’Andrea, Elvira, Elisabetta Patorno, Jessica M. Franklin, et al.. (2021). How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools. BMJ Open. 11(3). e043961–e043961. 13 indexed citations

Francisco, Gerard E., Wolfgang H. Jost, Ganesh Bavikatte, et al.. (2020). Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician‐ and Patient‐Reported Satisfaction: Long‐Term Observational Results from the ASPIRE Study. PM&R. 12(11). 1120–1133. 17 indexed citations

10.

Francisco, Gerard E., Daniel S. Bandari, Ganesh Bavikatte, et al.. (2020). High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study. SHILAP Revista de lepidopterología. 7. 100040–100040. 11 indexed citations

11.

Francisco, Gerard E., Daniel S. Bandari, Ganesh Bavikatte, et al.. (2017). The Adult Spasticity International Registry (ASPIRE) Study: 1-Year Results (P4.034). Neurology. 88(16_supplement). 1 indexed citations

12.

Largent, Joan, Michael G. Oefelein, Hilton M. Kaplan, Ted Okerson, & Peter Boyle. (2012). Risk of lymphoma in women with breast implants. European Journal of Cancer Prevention. 21(3). 274–280. 26 indexed citations

13.

Largent, Joan, Bruce G. Nickerson, Dan M. Cooper, & R J Delfino. (2012). Paediatric asthma hospital utilization varies by demographic factors and area socio-economic status. Public Health. 126(11). 928–936. 37 indexed citations

14.

Jewell, Mark L., Scott L. Spear, Joan Largent, Michael G. Oefelein, & William P. Adams. (2011). Anaplastic Large T-Cell Lymphoma and Breast Implants. Plastic & Reconstructive Surgery. 128(3). 651–661. 56 indexed citations

15.

Zell, Jason A., Argyrios Ziogas, Leslie Bernstein, et al.. (2010). Meat Consumption, Nonsteroidal Anti-Inflammatory Drug Use, and Mortality among Colorectal Cancer Patients in the California Teachers Study. Cancer Prevention Research. 3(7). 865–875. 18 indexed citations

16.

Largent, Joan, Leslie Bernstein, Pamela L. Horn‐Ross, et al.. (2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes & Control. 21(10). 1615–1624. 46 indexed citations

17.

Ma, Huiyan, Katherine D. Henderson, Jane Sullivan‐Halley, et al.. (2010). Pregnancy-related factors and the risk of breast carcinoma in situand invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Research. 12(3). R35–R35. 75 indexed citations

18.

Canchola, Alison J., Ellen T. Chang, Leslie Bernstein, et al.. (2010). Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort. Cancer Causes & Control. 21(12). 2241–2248. 20 indexed citations

19.

Figueiredo, Jane C., Robert W. Haile, Leslie Bernstein, et al.. (2009). Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Research and Treatment. 120(1). 175–183. 19 indexed citations

20.

McEligot, Archana J., Joan Largent, Argyrios Ziogas, David Peel, & Hoda Anton‐Culver. (2006). Dietary Fat, Fiber, Vegetable, and Micronutrients Are Associated With Overall Survival in Postmenopausal Women Diagnosed With Breast Cancer. Nutrition and Cancer. 55(2). 132–140. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact